Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy

Cheng-lin Liu; Yuan-dong Wang; Yuan-dong Jin; Li-ping Liu; Qing-wei Yu; Yu-cheng Cai

doi:10.1007/BF02934361

Your Location：

Home >

Browse articles >

Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy

Updated：2021-08-27

- Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy
- Chinese Journal of Integrative Medicine Vol. 7, Issue 4, Pages: 242-246(2001)
- Affiliations：
  
  1. Clinical Center of Tumor Research, Guangzhou Medical College, Guangzhou Municipal Tumor Hospital,Guangzhou
  2. First People’s Hospital of Zhaoqing,Guangdong Province,China
- Author bio：
- Funds：
- DOI：10.1007/BF02934361
  CLC：
- Published：2001，
Scan for full text
Liu, Cl., Wang, Yd., Jin, Yd. et al. Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy., CJIM 7, 242–246 (2001). https://doi.org/10.1007/BF02934361

Cheng-lin Liu, Yuan-dong Wang, Yuan-dong Jin, et al. Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy. [J]. Chinese Journal of Integrative Medicine 7(4):242-246(2001)
Liu, Cl., Wang, Yd., Jin, Yd. et al. Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy., CJIM 7, 242–246 (2001). https://doi.org/10.1007/BF02934361 DOI：

Cheng-lin Liu, Yuan-dong Wang, Yuan-dong Jin, et al. Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy. [J]. Chinese Journal of Integrative Medicine 7(4):242-246(2001) DOI： 10.1007/BF02934361.

摘要

To study the therapeutic effect of Chinese herbal medicine (CHM) combined with bronchial arterial chemotherapy (BAC) in treating lung cancer. Ninety patients with mid-advanced non-small cell lung cancer (NSCLC) were randomly divided into two groups. The 45 cases in Group A were treated with CHM combined with BAC and the 45 cases in Group B treated with BAC alone The short-term and long-term effect

follow-up survival rate

quality of life

changes of clinical symptoms and peripheral blood figures in the patients were observed. After treatment

the rate of CR + PR + NC in the two groups was 88.89% and 68.89% respectively

the inter-group comparison showed a significant difference (P<0.05). The 0.5-

1- and 2-year survival rate in Group A was 75.56%

55.56% and 48.89% respectively and in Group B71.11%

46.67% and 24.44% respectively. The 2-year survival rate in the former was better than that in the latter (P<0.05) Moreover

the improvement of clinical symptoms

Karnofsky scoring

body weight and peripheral blood figure in Group A was superior to those in Group B. Therapeutic effect of BAC could be enhanced by combining it with CHM.

Abstract

follow-up survival rate

quality of life

changes of clinical symptoms and peripheral blood figures in the patients were observed. After treatment

the rate of CR + PR + NC in the two groups was 88.89% and 68.89% respectively

the inter-group comparison showed a significant difference (P<0.05). The 0.5-

1- and 2-year survival rate in Group A was 75.56%

55.56% and 48.89% respectively and in Group B71.11%

46.67% and 24.44% respectively. The 2-year survival rate in the former was better than that in the latter (P<0.05) Moreover

the improvement of clinical symptoms

Karnofsky scoring

body weight and peripheral blood figure in Group A was superior to those in Group B. Therapeutic effect of BAC could be enhanced by combining it with CHM.

关键词

lung tumorinterventional chemotherapybronchial arterial chemotherapyChinese Herbal Medicine

Keywords

lung tumorinterventional chemotherapybronchial arterial chemotherapyChinese Herbal Medicine

references

National Office of Tumor Prevention and Treatment, et al. Norm of Prevention and Treatment of Often Encountered Malignant Tumor in China — Primary Bronchial Carcinoma. Beijing: Combined Publishing of Beijing Medical University and Peking Union Medical Universi ty, 1990: 1–19.

Li JG, Qu SB. Collection of Tumor Prevention and Treatment with TCM. 1st edit. Beijing: Publishing House of Scientific and Technological Literature, 1994: 291–292.

Tang ZY. Modem Oncology. 1st edit. Shanghai: Publishing House of Shanghai Medical University, 1993: 625, 425.

Ministry of Health of PRC. Guidance on Principle of Clinical Study on New Drugs of Traditional Chinese Medicine. Vol.3. 1997: 6–36.

Zheng RH, Dong YH, Zhou KR, et al. Study on blood supply of lung in bronchial carcinoma. Chin J Oncology 1995;17(1): 53–55.

Liu ZJ, Zhou WQ, Yuan JH, et al. Observation on 227 cases of mid-later stage pulmonary carcinoma treatment with bronchial arterial infusion of anti-tumor drugs. Chin J Radiology 1990;24(suppl.): 1.

Shan H, Luo PF, Li YH. Clinical Interventional Diagnosis and Therapy. Guangzhou: Guangdong Publishing House of Science and Technology, 1997: 78–81.

Huang ZM, Long H. Assessment on therapeutic effect of treatment of late stage non-small cell lung carcinoma by Chinese herbal medicine combined with chemotherapy. Chin J Integr Med 1997; 17(1): 26–28.

FULL TEXT LINK

More>

Views

393

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Development is a high level inheritance for China Time-honored Brand products

Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease

Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome

Effects and mechanisms of actions of Chinese herbal medicines for asthma

Related Author

No data

Related Institution

Cardiovascular Diseases Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences

The First Affiliated Hospital of Medical College of Zhejiang University

Zhejiang University of Chinese Medicine

Institute of Integrative Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

The First Affiliated Hospital of Medical School of Zhejiang University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰